Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMEDNYSE:CHENASDAQ:LHCGNASDAQ:OPCH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMEDAmedisys$96.370.0%$95.49$82.15▼$98.95$3.16B0.94420,241 shs102,655 shsCHEChemed$478.17-1.2%$561.01$473.55▼$623.61$7.02B0.5109,906 shs34,519 shsLHCGLHC Group$169.81$166.14$115.32▼$169.84$5.27B0.43576,665 shsN/AOPCHOption Care Health$31.40-1.7%$32.09$21.39▼$35.53$5.15B0.731.86 million shs143,324 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMEDAmedisys-2.04%-1.30%+2.11%+3.66%-0.31%CHEChemed-0.33%-13.15%-15.84%-21.29%-10.37%LHCGLHC Group0.00%0.00%0.00%0.00%0.00%OPCHOption Care Health-1.63%-0.96%-2.68%-8.16%+16.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMEDAmedisys2.8334 of 5 stars1.11.00.05.02.51.71.3CHEChemed4.9698 of 5 stars3.53.03.34.92.32.52.5LHCGLHC GroupN/AN/AN/AN/AN/AN/AN/AN/AOPCHOption Care Health4.12 of 5 stars2.44.00.04.22.41.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMEDAmedisys 2.25Hold$100.754.54% UpsideCHEChemed 3.00Buy$645.0034.89% UpsideLHCGLHC Group 0.00N/AN/AN/AOPCHOption Care Health 2.88Moderate Buy$35.5013.08% UpsideCurrent Analyst Ratings BreakdownLatest OPCH, LHCG, AMED, and CHE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$674.00 ➝ $640.006/30/2025CHEChemedBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$708.00 ➝ $650.006/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.004/30/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.00 ➝ $38.004/30/2025OPCHOption Care HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$38.00 ➝ $40.004/28/2025CHEChemedRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$667.00 ➝ $674.004/22/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.00 ➝ $36.004/21/2025OPCHOption Care HealthBarrington ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$38.00 ➝ $38.004/16/2025AMEDAmedisysRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$100.00 ➝ $100.00(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMEDAmedisys$2.35B1.35$6.10 per share15.79$36.03 per share2.67CHEChemed$2.43B2.88$25.25 per share18.94$74.35 per share6.43LHCGLHC Group$2.22B2.37$7.51 per share22.60$52.17 per share3.25OPCHOption Care Health$5.00B1.03$1.59 per share19.75$8.25 per share3.81Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMEDAmedisys$43.23M$2.7135.5819.911.343.79%12.52%7.01%7/23/2025 (Estimated)CHEChemed$302M$20.5323.3720.522.0212.40%27.58%18.96%7/23/2025 (Estimated)LHCGLHC Group$115.73M$2.0582.8335.2322.732.73%8.13%4.63%N/AOPCHOption Care Health$211.82M$1.2425.3524.921.964.12%16.90%7.00%7/30/2025 (Estimated)Latest OPCH, LHCG, AMED, and CHE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025OPCHOption Care Health$0.40N/AN/AN/A$1.35 billionN/A7/23/2025Q2 2025AMEDAmedisys$1.39N/AN/AN/A$614.61 millionN/A7/23/2025Q2 2025CHEChemed$6.02N/AN/AN/A$650.60 millionN/A4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion4/23/2025Q1 2025AMEDAmedisys$1.13$1.25+$0.12$1.84$597.43 million$594.78 million4/23/2025Q1 2025CHEChemed$5.59$5.63+$0.04$4.86$641.78 million$646.94 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMEDAmedisysN/AN/AN/AN/AN/ACHEChemed$2.000.42%N/A9.74%16 YearsLHCGLHC GroupN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ALatest OPCH, LHCG, AMED, and CHE DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/20/2025CHEChemedquarterly$0.500.3%5/29/20255/29/20256/17/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMEDAmedisys0.271.291.29CHEChemedN/A1.731.70LHCGLHC Group0.441.451.45OPCHOption Care Health0.821.541.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMEDAmedisys94.36%CHEChemed95.85%LHCGLHC Group83.47%OPCHOption Care Health98.05%Insider OwnershipCompanyInsider OwnershipAMEDAmedisys2.10%CHEChemed3.29%LHCGLHC Group4.80%OPCHOption Care Health0.64%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMEDAmedisys19,00032.82 million32.13 millionOptionableCHEChemed14,20014.63 million14.15 millionOptionableLHCGLHC Group30,00031.03 million29.54 millionOptionableOPCHOption Care Health5,600163.75 million162.70 millionOptionableOPCH, LHCG, AMED, and CHE HeadlinesRecent News About These CompaniesOption Care Health Shows Improved Relative Strength; Still Shy Of BenchmarkJune 30 at 7:54 PM | msn.comAllspring Global Investments Holdings LLC Boosts Stake in Option Care Health, Inc. (NASDAQ:OPCH)June 30 at 4:47 AM | marketbeat.comOption Care Health (NASDAQ:OPCH) and Daxor (NASDAQ:DXR) Financial ReviewJune 30 at 2:39 AM | americanbankingnews.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Villere ST Denis J & Co. LLCJune 28, 2025 | marketbeat.comOppenheimer Asset Management Inc. Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 28, 2025 | marketbeat.comBTSG vs. OPCH: Which Home Infusion Stock is a Better Buy Now?June 26, 2025 | zacks.comOption Care Health to Announce Second Quarter 2025 Financial Results and Host Conference CallJune 25, 2025 | globenewswire.comOption Care Health’s Q1 Earnings Call: Our Top 5 Analyst QuestionsJune 23, 2025 | finance.yahoo.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Avior Wealth Management LLCJune 22, 2025 | marketbeat.comSG Americas Securities LLC Makes New Investment in Option Care Health, Inc. (NASDAQ:OPCH)June 21, 2025 | marketbeat.comRiverbridge Partners LLC Has $50.64 Million Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.comJanney Capital Management LLC Purchases New Position in Option Care Health, Inc. (NASDAQ:OPCH)June 20, 2025 | marketbeat.com1OPCH : Forecasting The Future: 5 Analyst Projections For Option Care HealthJune 18, 2025 | benzinga.comJMP Securities Reaffirms "Market Outperform" Rating for Option Care Health (NASDAQ:OPCH)June 18, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 17, 2025 | marketbeat.comAssenagon Asset Management S.A. Lowers Position in Option Care Health, Inc. (NASDAQ:OPCH)June 15, 2025 | marketbeat.comFort Washington Investment Advisors Inc. OH Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)June 13, 2025 | marketbeat.comHere’s Why Option Care Health (OPCH) Surged in Q1June 12, 2025 | msn.comGAMMA Investing LLC Acquires 110,776 Shares of Option Care Health, Inc. (NASDAQ:OPCH)June 12, 2025 | marketbeat.comHarbor Capital Advisors Inc. Reduces Position in Option Care Health, Inc. (NASDAQ:OPCH)June 11, 2025 | marketbeat.comOption Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Wedge Capital Management L L P NCJune 10, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeOPCH, LHCG, AMED, and CHE Company DescriptionsAmedisys NASDAQ:AMED$96.37 -0.01 (-0.01%) As of 10:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.Chemed NYSE:CHE$478.17 -5.75 (-1.19%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.LHC Group NASDAQ:LHCGLHC Group, Inc. provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations. The Home Health segment offers a wide range of services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education. The Hospice Services segment offer a wide range of services, including pain and symptom management, emotional and spiritual support, inpatient and respite care, homemaker services, and counseling. The Home & Community-Based Services segment are performed by paraprofessional personnel, and include assistance to the elderly, chronically ill, and disabled patients with activities of daily living. The Facility Based Services segment includes long-term acute care hospitals treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical persoOption Care Health NASDAQ:OPCH$31.40 -0.56 (-1.74%) As of 10:45 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Reasons to Buy Trade Desk Stock Now and 1 Warning Sign Toast Stock: A Fast-Growing Mid-Cap Eyeing Further Upside Breakout Alert: Disney Stock Hits Multi-Year High 2 Under the Radar Space & Defense Stocks With Huge Potential Why Realty Income’s 5.59% Yield Makes It a Must-Buy REIT Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Forget IBM: Accenture’s AI Momentum Is Your Next Buy Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
